Terms: = Colorectal cancer AND SLC34A2, ENSG00000157765, O95436, NPTIIb, NAPI-IIb, NAPI-3B, FLJ90534, 10568 AND Prognosis
2 results:
1. slc34a2 promotes cancer proliferation and cell cycle progression by targeting TMPRSS3 in colorectal cancer.
Yang Y; Wu J; Yu X; Wu Q; Cao H; Dai X; Chen H
Pathol Res Pract; 2022 Jan; 229():153706. PubMed ID: 34929599
[TBL] [Abstract] [Full Text] [Related]
2. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
Liu L; Yang Y; Zhou X; Yan X; Wu Z
Biomed Pharmacother; 2018 Mar; 99():645-654. PubMed ID: 29653487
[TBL] [Abstract] [Full Text] [Related]